Gliosarcoma Clinical Trials

123 clinical trials for Gliosarcoma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma — RECRUITING · PHASE2
• ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial — RECRUITING · PHASE1
• Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma — RECRUITING · PHASE1
• A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma — RECRUITING · PHASE1
• Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue — RECRUITING
• Study of Pembrolizumab and M032 (NSC 733972) — RECRUITING · PHASE1
• A PHASE II, MULTI-CENTER, OPEN-LABEL STUDY OF A CONDITIONALLY REPLICATIVE ADENOVIRUS (DNX-2401) WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA OR GLIOSARCOMA (CAPTIVE) — RECRUITING · PHASE2
• SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme — ACTIVE_NOT_RECRUITING · PHASE2
• Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE1
• DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma — ACTIVE_NOT_RECRUITING · NA
• Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE3
• Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) — SUSPENDED · PHASE1
• Natural Progesterone for the Treatment of Recurrent Glioblastoma — TERMINATED · PHASE1
• Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma — COMPLETED · PHASE2
• Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma — COMPLETED · PHASE2
• Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE1
• Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE2
• Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma — TERMINATED · PHASE1
• Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma — ACTIVE_NOT_RECRUITING · PHASE1
• Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma — COMPLETED · PHASE1
• Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma — COMPLETED · PHASE2
• Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer — TERMINATED · PHASE1
• Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma — COMPLETED · PHASE1
• Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab — COMPLETED · PHASE2
• Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma — COMPLETED · PHASE2
• Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma — COMPLETED · PHASE1
• Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy — TERMINATED · PHASE1
• ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme — OTHER · PHASE2
• Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery — TERMINATED · PHASE2
• Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma — TERMINATED · PHASE1
• Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma — COMPLETED · PHASE1
• Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG — TERMINATED · PHASE2
• Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma — COMPLETED · PHASE2
• Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children — COMPLETED · PHASE1
• Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma — TERMINATED · PHASE1
• Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors — COMPLETED · PHASE1
• Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas — COMPLETED · PHASE1
• Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma — TERMINATED · PHASE1
• Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma — COMPLETED · PHASE1
• Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) — COMPLETED · PHASE1
• INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme — COMPLETED · PHASE1
• Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma — COMPLETED · PHASE1
• Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas — TERMINATED · PHASE1
• A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification — COMPLETED · PHASE3
• Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma — COMPLETED · PHASE1
• EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma — TERMINATED · PHASE1
• Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas — COMPLETED · PHASE2
• Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma — COMPLETED · PHASE1

Refine this search